Main Conference Day 2 (2nd September 2026)
Main Conference Day 2 (2nd September 2026)
08:00 - 09:1575 mins
Breaks & Networking
Registration and Coffee
09:15 - 09:205 mins
Keynote Session: Transforming Biomanufacturing Through Digital Innovation - Part II
Chairperson's Opening Remarks
- Chervee Ho - CEO and Co-Founder, Biochromatographix
09:20 - 09:5535 mins
Keynote Session: Transforming Biomanufacturing Through Digital Innovation - Part II
Keynote Address: AI-Guided Nanoscale Modeling for Accelerated Drug Discovery and Translation
- Raye Yeow, Ph.D. - Dean’s Chair Professor, National University of Singapore
09:55 - 10:3035 mins
Keynote Session: Transforming Biomanufacturing Through Digital Innovation - Part II
Keynote Address: Building Next-Generation Digitally Enabled Biomanufacturing Facilities
- Makoto Sadamitsu - Head, Integrated Early Process Development, Biotherapeutics Process Development, Takeda Pharmaceutical Company Limited
10:30 - 11:0030 mins
Breaks & Networking
Networking Refreshment Break in Exhibit/Poster Hall
11:00 - 11:3030 mins
Building Resilient and Sustainable Bioprocesses: Strategies for the Future of Biomanufacturing
Future-Proof Bioprocessing: Building Climate-Resilient, Target Net-Zero Biopharma Operations Through Data-Driven Design
- Yuki Abe, Ph.D. - Director, BioPharm Services Ltd.
11:30 - 12:0030 mins
Building Resilient and Sustainable Bioprocesses: Strategies for the Future of Biomanufacturing
Panel Discussion: Turning Sustainability into Practice: Real-World Strategies for Resilient Bioprocessing
- Yuki Abe, Ph.D. - Director, BioPharm Services Ltd.
- Makoto Sadamitsu - Head, Integrated Early Process Development, Biotherapeutics Process Development, Takeda Pharmaceutical Company Limited
12:00 - 12:3030 mins
Building Resilient and Sustainable Bioprocesses: Strategies for the Future of Biomanufacturing
Scientific Track Presentation
12:30 - 13:5585 mins
Breaks & Networking
Luncheon and Innovation Spotlight: Poster Pitch Showcase
13:55 - 14:005 mins
Overcoming Challenges in Developing Novel Modalities - Manufacturing the Next Generation of Biologics
Chairperson's Remarks
- Stefano Menegatti - Professor, Chemical and Biomolecular Engineering, NC State University, North Carolina State University
14:00 - 14:3030 mins
Overcoming Challenges in Developing Novel Modalities - Manufacturing the Next Generation of Biologics
Advances in Downstream Processing for mRNA and VLP
- Lukas Gerstweiler, Ph.D. - Senior Lecturer, Adelaide University
14:30 - 15:0030 mins
Overcoming Challenges in Developing Novel Modalities - Manufacturing the Next Generation of Biologics
Monoliths, Fibers, and Gigapores - The Next Generation of Chromatography Media for Novel Modalities
- Alois Jungbauer - Professor, Dept. of Biotechnology, University of Natural Resources and Applied Life Sciences
15:00 - 15:3030 mins
Overcoming Challenges in Developing Novel Modalities - Manufacturing the Next Generation of Biologics
Scientific Track Presentation
15:30 - 16:0030 mins
Breaks & Networking
Networking Refreshment Break in Exhibit/Poster Hall
16:00 - 16:3030 mins
Overcoming Challenges in Developing Novel Modalities - Manufacturing the Next Generation of Biologics
Innovative Downstream Processing for Bi-Specific Antibody
- Wei Zhang - Associate Staff Scientist, Downstream Processing Group, Bioprocessing Technology Institute of Singapore, A*STAR
16:30 - 17:0030 mins
Overcoming Challenges in Developing Novel Modalities - Manufacturing the Next Generation of Biologics
Engineering and Manufacturing Strategies for Multispecific Antibodies
- Tomoyuki Igawa, Ph.D. - Head of Research, Chugai Pharmaceutical Co., Ltd.
17:00 - 17:3030 mins
Overcoming Challenges in Developing Novel Modalities - Manufacturing the Next Generation of Biologics
[BioPhorum Case Study] The Future of Manufacturing Operations
- Andrea Johnston - Senior Director, BioPhorum
- William Doyle - Business Technology Partner, MSD, Ireland
17:30 - 17:355 mins
Breaks & Networking
Close of BPI APAC 2026
* 不測の事態により、事前の予告なしにプログラムが変更される場合があります。